| Financial Year |
March 31 2023 |
| Monetary Funds |
3,634,007,434.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
940,383.74 |
| Accounts Receivable |
447,176,241.31 |
| Advances to Suppliers |
72,862,565.21 |
| Other Receivables |
615,875,425.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
597,130,215.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
228,807,931.10 |
| Total Current Assets |
7,066,450,291.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,061,170.77 |
| Long-term Equity Investment |
2,452,992,764.49 |
| Investment Properties |
136,204,067.31 |
| Fixed Assetes |
16,600,451,421.60 |
| Under-construction Projects |
1,578,649,645.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,918,853,515.74 |
| R&D expenses |
-- |
| Goodwill |
22,610,400.16 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
46,240,398.28 |
| Other Non-Current Assets |
115,541,663.59 |
| Sub-Total of Non-Current Assets |
25,829,789,533.08 |
| Total Assets |
32,896,239,824.59 |
| Short-Term Loans |
1,191,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,499,625,270.35 |
| Accounts Received In Advance |
278,021.77 |
| Employee Compensation Payable |
171,587,844.31 |
| Taxes Payable |
136,391,313.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,149,011,415.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
260,210,204.97 |
| Other Current Liabilities |
236,037.74 |
| Sub-Total of Current Liabilities |
7,429,297,096.05 |
| Long-term Loans |
3,406,694,967.64 |
| Bonds Payable |
3,000,000,000.00 |
| Long-Term Accounts Payable |
93,590,626.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
37,613,509.72 |
| Deferred Income Tax Liabilities |
56,714,213.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,987,006,623.56 |
| Total Liabilities |
15,416,303,719.61 |
| Paid-In Capital(Or Share Stock) |
4,800,000,000.00 |
| Capital Surplus |
4,806,246,601.77 |
| Surplus Reserve |
2,038,258,219.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,426,347,152.48 |
| Minority Stockholder's Interest |
101,366,839.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,378,569,265.08 |
| Owner's Equity（Stockholder's Equity） |
17,479,936,104.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,896,239,824.59 |
